 Baseline biometric/smoking values were the most recent available measure prior to the program order date. Follow-up biometric/smoking values were the measure closest to 6 months after the program order date (within range of 2-12 months).  Behavioral measures other than smoking were only available for enrollees.
Baseline measures are those from their first phone encounter and follow up measures are from the phone encounter closest to 6 months after enrollment.  Study design compares participants to eligible non-participants (i.e., opt-outs or unresponsive to mail/phone outreach attempts) for changes in biometric values.  Mixed model analysis of variance was used to compare changes in measures for non-enrollees, enrollees with 1-4 encounters, and enrollees with > 5 encounters.
 HBC enrollees significantly improved LDL and smoking status in high CVD risk adults compared to non-enrollees.  Enrollees saw increased improvement in fruit and vegetable consumption, physical activity, stress level, aspirin use, medication use/adherence.
 Increased encounters were associated with larger magnitude of changes in LDL, medication use, and stress.  Positive changes in the non-participant group may be attributed to the broader HONU project and the interventions available in worksites and throughout the community. Additionally, bi-annual provider trainings are conducted to provide physicians and midlevel providers with an opportunity to learn about the role of the medical provider in the project and available treatment options for the management of all individuals at high risk for CHD.
 Such real-world, systems-based innovations can serve as a platform to target and engage at-risk populations, thereby enhancing primary CVD care in rural and other underserved areas.
. .  1035 patients who were eligible for the HBC program were included in the study sample. Of these, 333 (32%) enrolled.  Among enrollees, 82% were still engaged in the program after six months.
 Enrollees and non-enrollees were comparable at baseline on age, marital status, blood pressure, cholesterol (total, HDL, LDL, triglycerides) and BMI. The groups differed on gender (non-enrollees were more likely to be male 55.4% vs. 47.1%) and smoking (23% smokers among non-enrollees vs. 16.8% among enrollees).
 Mixed model analyses indicated a significant group-by-time interaction for LDL cholesterol (p=0.001). Over six months, non-enrollees lowered their LDL by 6.5 mg/dL, whereas HBC enrollees who completed 1-4 and > 5 telephone encounters lowered their LDL by 4.5 and 16.1 mg/dL, respectively. The proportion who met the program goal of LDL <100 mg/dL increased by 69% in enrollees (vs. 24% in nonenrollees).
 Smoking decreased significantly among enrollees; it was the only measure that saw the most improvement among those with fewer encounters. Among enrollees, smoking decreased by 67% in those with 1-4 encounters compared to 33% in those with > 5 encounters and 21% in non-enrollees.
 Enrollees saw improvements in behavioral risk factors with increased improvement for those with more encounters for stress, medication use, and medication adherence. All participants were included in the analyses and all outcomes were adjusted for age, sex, and days between baseline and follow-up measurements.
RESULTS
Continuous outcomes are reported as mean ±standard error, and categorical outcomes are reported as percent of sample. * Significant (within-group) change between baseline and follow-up (p<0.05) Change scores with different superscript letters are significantly different from one another (p<0.05) Table 1 : Model-based changes in targeted risk factors among adults at high CVD risk who were invited to participate in the HBC program, stratified by level of program engagement 
